Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$25.97−0.45 (-1.70%)
Close on Nov 17, 2026Market cap $996.68MP/E –Yield –
Ceribell price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Ceribell's price to book ratio was 8.3× on Nov 11, 2026, against 3.8× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 8.3× | +3.3 |
| 2025 | Dec 31, 2025 | 5.0× | – |
See a number that looks wrong?